Human Genome Epidemiology Literature Finder
Records 1 - 2 (of 2 Records) |
Query Trace: Stomatitis and KRAS[original query] |
---|
FOLFOXIRI in combination with panitumumab as first-line treatment in quadruple wild-type (KRAS, NRAS, HRAS, BRAF) metastatic colorectal cancer patients: a phase II trial by the Gruppo Oncologico Nord Ovest (GONO). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013 Aug 24 (8): 2062-7. Fornaro L, Lonardi S, Masi G, Loupakis F, Bergamo F, Salvatore L, Cremolini C, Schirripa M, Vivaldi C, Aprile G, Zaniboni A, Bracarda S, Fontanini G, Sensi E, Lupi C, Morvillo M, Zagonel V, Falcone |
A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas. European journal of cancer (Oxford, England : 1990) 2014 Aug 50 (12): 2072-81. Infante Jeffrey R, Somer Bradley G, Park Joon Oh, Li Chung-Pin, Scheulen Max E, Kasubhai Saifuddin M, Oh Do-Youn, Liu Yuan, Redhu Suman, Steplewski Klaudia, Le Ngocdi |
- Page last reviewed:Feb 1, 2024
- Content source: